1. Might Template CoMFA Integrate Structure-Based and Ligand-BasedDesign? Some Remarkable PredictionsRichard D. Cramer ([email protected])EuroQSAR 2014, St. Petersburg, Russian…
Slide 1Drugs and Coagulation at Point-of-Care Stacie Krick Evans, Pharm.D. Orlando Regional Medical Center Slide 2 Objectives Review the mechanisms of action between oral…
1. DVT PROPHYLAXIS Dr. E M. Regis Jr. Dept. Of Orthopaedics 10/08/15 2. Overview Definition Incidence Aeitology/ Risk Factors Pathophysiology Signs/ Symptoms Diagnosis Complications…
Slide 1 Clinical Research in Central Oregon Archie Bleyer, MD SCHS What’s Available to You, to Our Community, and Why Tim Beard, MD BMC Slide 2 Objectives 1)Understand…
Apixaban: Farmakologický profil M.Táborský XX. Výroční sjezd ČKS Brno, 16.5.2012 BMS/Pfizer confidential. For internal use only. Not for further distribution. APIXABAN…
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy Shannon M. Bates, MDCM, MSc Ian A. Greer, MD, FMedSci, FCCP Saskia Middeldorp, MD, PhD David Veenstra, PharmD,…